Background: Limitations of Conventional Linear Vaccine Design and Epitope-Codon Matching Data Bottlenecks in Variant Antigen R&D

The existing vaccine development paradigm relies on physical, wet-lab-based screening and empirical baselines, exposing its limitations in keeping pace with rapidly evolving genetic variants. In particular, the post-hoc, empirical design process fails to control the flux variations caused by the degradation of linear mRNA that enters target cells, due to the disruptive structural collapse and ribonucleolytic attack within the intracellular microenvironment. This leads to ribosomal stalling and a sharp decline in translational efficiency during interaction with the host's translational machinery, creating a critical blind spot that fails to maintain effective concentrations for successful engraftment. Furthermore, existing codon optimization guidelines are biased towards maximizing only the linear codon adaptation index, failing to computationally address the trade-off between essential secondary structure stability and GC content in mRNA. This results in repeated failures in controlling rapid expression attenuation after initial immunogenicity induction, acting as a bottleneck that prevents overcoming batch effects and interspecies immune receptor binding free energy deviations at the IND approval stage.

Discovery: Implementation of a Multiple Sequence Alignment-Based Epitope Prediction Algorithm and Demonstration of Single-Cell Resolution Codon-GC Content Tensor Synchronization

To overcome these limitations, this computational systems biology framework integrates a multiple sequence alignment algorithm with a deep learning-based antigen epitope prediction model to precisely identify conserved antigen domains. By converting inter-variant genetic gradients into multidimensional tensors and removing batch effects in real-time on the computational platform, the optimal common sequence is derived. Subsequently, codon adaptation and GC content balancing are combined with a differential equation-based rate constant algorithm to perform a computational scan that minimizes the free energy of the mRNA secondary structure. The optimized design loop predicts the electrostatic binding free energy with lipid nanoparticle formulations in silico, proactively maximizing intracellular encapsulation rate and endosomal escape velocity. This high-precision, independent variable tensor synchronization demonstration surpasses the integrated area of in vitro and in vivo expression trajectories compared to conventional classical models, elucidating the topological variation curve of the downstream transcriptome network and demonstrating molecular biological integrity.

Tuning of Ribosomal Lag Control Pathways and Establishment of a Reversible, Layered Immunological Homeostasis Model

The core of this architecture lies in the establishment of a reversible, layered immunological homeostasis model that tunes the host ribosome's translation initiation and elongation kinetics. By layering the immunological presentation intensity of target epitopes based on patient and population-specific HLA allele omics matrices, personalized immune induction is enabled. By operating up- and down-regulation techniques that artificially regulate the availability of tRNA and codon frequency, which determine the rate-limiting step constants, the optimal expression dynamics that can continuously stimulate immune receptors are induced without burdening the host cell's genetic translation system. This physically controls the temporal trajectory of antigen expression, suppressing excessive systemic inflammatory responses and precisely shaping the activation landscape of adaptive immune cells. As a result, it provides a computational backbone that maintains effective vaccine concentrations exceeding the in vivo effective response threshold for a long period and can reversibly restore homeostasis even under aberrant physiological stress conditions.

Prospects: Establishment of a Programmable Computational Systems Biology Standard and Implementation of a Next-Generation IND Digital Governance System

This in silico design methodology will play a pivotal role in establishing a programmable preventive medicine standard in the future global pharmaceutical and biotechnology ecosystem. By departing from conventional random screening methods and precisely synchronizing the immune gradient correction coefficients of vaccine candidates based on digital tensors, it provides a computational moat that eliminates batch-to-batch variations in large-scale clinical trials by multinational corporations. Furthermore, this system meets the biomarker companion diagnostic (CDx) specifications, enabling predictable immune induction levels, thereby disruptively shortening the timelines for clinical trial planning approval and cGMP process qualification assessment by the US FDA and other regulatory agencies. Ultimately, it will implement a next-generation digital governance system that can reverse-engineer the optimal mRNA sequence and LNP formulation parameters with guaranteed stability and efficacy within a few days when a new variant pathogen emerges, completely eliminating the temporal gap in pandemic response and establishing itself as a core technology asset that guarantees the safety of the global biosupply chain.